i
Important informations

LDI

The Lady Davis Institute for Medical Research

The research arm of the Jewish General Hospital

The LDI is among Canada’s leading health research institutes. Through their fundamental and clinical investigations, our scientists and clinicians make significant discoveries, lead important provincial and national research programs, and train emerging scientists who, themselves, are recognized for the excellence of their work, contributing to the health and well-being of patients in Quebec, Canada, and around the world.

Empowering research excellence and innovation

At the Lady Davis Institute for Medical Research (LDI), equity, diversity and inclusion are at the heart of who we are. We are committed to provide people working in the LDI community with exemplary, highest quality of work and learning environments that are healthy, equitable and inclusive, free from all forms of discrimination and where every person can feel welcomed and recognized, but also involved and contributing to the present and the future of the LDI.

Discover our 200+ regular and associated investigators and their research, as well as the many services we provide across the spectrum of the research process.

We offer the 250+ graduate and postdoctoral students who come to the LDI each year an open, collaborative, and multidisciplinary training environment that fosters excellence.

The close collaboration between researchers, clinicians, and patients is at the basis of the most successful research programs and clinical trials at the LDI.

Empowering research excellence and innovation

At the Lady Davis Institute for Medical Research (LDI), equity, diversity and inclusion are at the heart of who we are. We are committed to provide people working in the LDI community with exemplary, highest quality of work and learning environments that are healthy, equitable and inclusive, free from all forms of discrimination and where every person can feel welcomed and recognized, but also involved and contributing to the present and the future of the LDI.

Latest News

Research news

Tweets

Cancer

Biomarkers, Gynecologic cancer, Robotic surgery

Clinical Epidemiology

Cardiology, Cardiovascular disease prevention, Clinical trials, E-cigarettes, Epidemiology, Meta-analysis, Smoking cessation, Systematic review

Cancer

Basal cell carcinoma, Biobanking, Biomarkers, Computational biology, Dermatology, Genomics, Skin cancer, Transcriptomics, Translational research, Tumor microenvironment

Clinical Epidemiology

Biostatistics, Genetic epidemiology, Statistical genetics

Cancer

Chromatin, Chromatin remodeling, Epigenetics, Gene expression, Histone acetylation, Histones, Nucleosome, RNAPII, Stem cells, Transcription

Molecular & Regenerative Medicine

Aging, DNA damage, DNA replication, Genome integrity, Post-translational modifications, Recombination, Ribonucleoprotein assembly, Telomerase, Telomere

Cancer

Arginine methylation and DNA damage, Breast cancer epigenetics, Drug design, RGG/RG motifs and G-quadruplexes, RNA binding proteins and neurological diseases

Molecular & Regenerative Medicine

AIDS/HIV, Infectious diseases, Innate immunity, RNA biology, RNA Interference, RNA Therapeutics, SARS-CoV-2, Virus-Cell interactions

National Collaborations and Partnerships

LDI logo
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.